Rubius Therapeutics Price Prediction
| RUBYDelisted Stock | USD 0.08 0.02 17.00% |
Oversold Vs Overbought
39
Oversold | Overbought |
Using Rubius Therapeutics hype-based prediction, you can estimate the value of Rubius Therapeutics from the perspective of Rubius Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Rubius Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Rubius because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Rubius Therapeutics after-hype prediction price | USD 0.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Rubius |
Rubius Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Rubius Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Rubius Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Rubius Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Rubius Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Rubius Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Rubius Therapeutics' historical news coverage. Rubius Therapeutics' after-hype downside and upside margins for the prediction period are 0.08 and 0.09, respectively. We have considered Rubius Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Rubius Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Rubius Therapeutics is based on 3 months time horizon.
Rubius Therapeutics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Rubius Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rubius Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Rubius Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 16 Events / Month | 4 Events / Month | In about 16 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.08 | 0.08 | 3.61 |
|
Rubius Therapeutics Hype Timeline
Rubius Therapeutics is at this time traded for 0.08. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Rubius is forecasted to decline in value after the next headline, with the price expected to drop to 0.08. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -3.61%, whereas the daily expected return is at this time at 0.0%. The volatility of related hype on Rubius Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.08. About 73.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Rubius Therapeutics recorded a loss per share of 2.27. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 16 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.Rubius Therapeutics Related Hype Analysis
Having access to credible news sources related to Rubius Therapeutics' direct competition is more important than ever and may enhance your ability to predict Rubius Therapeutics' future price movements. Getting to know how Rubius Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Rubius Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MGTA | Magenta Therapeutics | (0.02) | 2 per month | 3.40 | (0) | 5.88 | (4.29) | 16.99 | |
| EVLO | Evelo Biosciences | (0.05) | 59 per month | 11.93 | 0.14 | 46.25 | (26.62) | 131.59 | |
| AVRO | AVROBIO | 0.05 | 5 per month | 1.89 | 0.01 | 4.11 | (3.17) | 14.20 | |
| SRRK | Scholar Rock Holding | (1.61) | 9 per month | 3.23 | 0.11 | 7.58 | (6.99) | 375.97 | |
| REPL | Replimune Group | (0.10) | 7 per month | 2.86 | 0.11 | 7.38 | (5.60) | 15.63 |
Rubius Therapeutics Additional Predictive Modules
Most predictive techniques to examine Rubius price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rubius using various technical indicators. When you analyze Rubius charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Rubius Therapeutics Predictive Indicators
The successful prediction of Rubius Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Rubius Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Rubius Therapeutics based on analysis of Rubius Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Rubius Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Rubius Therapeutics's related companies.
Story Coverage note for Rubius Therapeutics
The number of cover stories for Rubius Therapeutics depends on current market conditions and Rubius Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Rubius Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Rubius Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Rubius Therapeutics Short Properties
Rubius Therapeutics' future price predictability will typically decrease when Rubius Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Rubius Therapeutics often depends not only on the future outlook of the potential Rubius Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rubius Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 90.4 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Rubius Pink Sheet
If you are still planning to invest in Rubius Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rubius Therapeutics' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |